Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acarbose versus placebo metabolomics study in adults with prediabetes
ChiCTR-TTRCC-13004112Phase 4Completed
- Sponsor
- Peking University People's Hospital
- Start
- Dec 2009
- Modality
- Microbiome-Derived Products → Microbiome Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of acarbose in prediabetes (2 arms), sponsored by Peking University People's Hospital. Primary endpoints: Metabolic profiles, Total cholesterol, triglycerides, HDL, LDL and 1 more. Started Dec 2009; status: completed.
02
Drugs
acarbose
03
Conditions
prediabetes
Beyond the preview
Go deeper on ChiCTR-TTRCC-13004112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TTRCC-13004112.